Last CNY6.64 CNY
Change Today -0.11 / -1.63%
Volume 1.3M
600829 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

harbin pharm. group sanjin-a (600829) Snapshot

Open
CNY6.73
Previous Close
CNY6.75
Day High
CNY6.73
Day Low
CNY6.60
52 Week High
10/17/13 - CNY8.34
52 Week Low
07/30/13 - CNY6.05
Market Cap
3.9B
Average Volume 10 Days
1.3M
EPS TTM
CNY0.03
Shares Outstanding
579.9M
EX-Date
07/11/14
P/E TM
231.2x
Dividend
CNY0.13
Dividend Yield
2.00%
Current Stock Chart for HARBIN PHARM. GROUP SANJIN-A (600829)

Related News

No related news articles were found.

harbin pharm. group sanjin-a (600829) Related Businessweek News

No Related Businessweek News Found

harbin pharm. group sanjin-a (600829) Details

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. produces and sells OTC products and prescription drugs in China and internationally. The company primarily produces and manages Chinese and western medicine in various dosage forms, including small volume injections, oral liquids, oral solutions, mixtures, aerosol, pills, dropping pills, raw medicines, sterile raw medicines, powder injections, little capacity injections, tablets, capsules, lotions, granules, spraying agents, freeze-dried injections, lyophilization injections, creams and ointments, eye drops, and other products. It is also involved in the wholesale of chemical preparations, Chinese patent medicine, antibiotics, biochemical medicine, chemical raw medicine, narcotics, and psychotropic drugs; and health foods. In addition, the company imports and exports goods and technologies, as well as other businesses. Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. was founded in 1950 and is based in Harbin, China.

Founded in 1950

harbin pharm. group sanjin-a (600829) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharm. group sanjin-a (600829) Key Developments

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. Declares Tax Included Cash Distribution for 2013, Payable on July 11, 2014

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. implemented the scheme of profit distribution of RMB 0.133 (taxes included) per share for 2013. Record date is July 10, 2014, ex-dividend date is July 11, 2014 and the cash dividend payable on July 11, 2014.

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., Board Meeting, Jun 25, 2014

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., Board Meeting, Jun 25, 2014. Agenda: To discuss and approve the proposal of providing entrusted loan for some wholly-owned subsidiary.

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd.(SHSE:600829) dropped from Shanghai Stock Exchange Health Care Sector Index

Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. will be removed from the Shanghai Stock Exchange Health Care Sector Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600829:CH CNY6.64 CNY -0.11

600829 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600829.
View Industry Companies
 

Industry Analysis

600829

Industry Average

Valuation 600829 Industry Range
Price/Earnings 100.0x
Price/Sales 1.3x
Price/Book 1.8x
Price/Cash Flow 213.6x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARM. GROUP SANJIN-A, please visit www.sanjing.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.